These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 30343148

  • 1. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
    Ying YQ, Hou L, Liang Y, Wu W, Luo XP.
    Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148
    [Abstract] [Full Text] [Related]

  • 2. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A.
    J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L, Liang Y, Wu W, Lin HH, Luo XP, Ying YQ.
    Growth Horm IGF Res; 2020 Oct 26; 53-54():101331. PubMed ID: 32777706
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ, Wang LH, Chen L.
    Adv Ther; 2019 Sep 26; 36(9):2374-2383. PubMed ID: 31301056
    [Abstract] [Full Text] [Related]

  • 5. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT.
    Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651
    [Abstract] [Full Text] [Related]

  • 6. A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency.
    Gou P, Cheng X, Leng J, Su N.
    Ther Clin Risk Manag; 2022 Mar 19; 18():113-124. PubMed ID: 35342293
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view.
    Ma Y, Sheng J, Wang L, Zhang Y, Liu L.
    Medicine (Baltimore); 2024 Jun 21; 103(25):e38350. PubMed ID: 38905369
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ, Kim EY, Shim YS, Jeong HR, Lee HJ, Yang S, Hwang IT.
    Medicine (Baltimore); 2019 Apr 21; 98(14):e14962. PubMed ID: 30946320
    [Abstract] [Full Text] [Related]

  • 9. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature.
    Wang W, Wang Y, Xiao Y, Cao N, Wang Y.
    BMC Pediatr; 2023 Dec 05; 23(1):615. PubMed ID: 38053091
    [Abstract] [Full Text] [Related]

  • 10. A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth.
    Rothenbuhler A, Ormières B, Kalifa G, Bougnères P.
    Growth Horm IGF Res; 2015 Apr 05; 25(2):96-102. PubMed ID: 25641639
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan 05; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 12. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 13. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study.
    Soliman AT, abdul Khadir MM.
    J Trop Pediatr; 1996 Oct 23; 42(5):281-6. PubMed ID: 8936959
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Human Growth Hormone in Idiopathic Short Stature.
    Tao S, Li G, Wang Q, Hu Y.
    Indian J Pediatr; 2015 Jul 23; 82(7):625-8. PubMed ID: 25893526
    [Abstract] [Full Text] [Related]

  • 15. Measurement of amino-terminal propeptide of C-type natriuretic peptide in patients with idiopathic short stature or isolated growth hormone deficiency.
    Xiao Y, Dong Z, Lu W, Wang X, Sun W, Wang D, Ni J, Chen F, Wang J, Wang W.
    J Pediatr Endocrinol Metab; 2011 Jul 23; 24(11-12):989-94. PubMed ID: 22308853
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul 23; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 17. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study.
    Xie L, Li Y, Zhang J, Guo S, Chen Q, Ma H, Jiang W.
    Eur J Pediatr; 2024 Oct 23; 183(10):4531-4539. PubMed ID: 39158594
    [Abstract] [Full Text] [Related]

  • 18. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF, Antonini SR, Guerra-Junior G, Mendonca BB, Arnhold IJ, Jorge AA.
    J Clin Endocrinol Metab; 2009 Feb 23; 94(2):588-95. PubMed ID: 18984657
    [Abstract] [Full Text] [Related]

  • 19. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J, Suh BK, Ko CW, Lee KH, Shin CH, Hwang JS, Kim HS, Chung WY, Kim CJ, Han HS, Kwon NY, Cho SY, Yoo HW, Jin DK.
    J Endocrinol Invest; 2018 Apr 23; 41(4):475-483. PubMed ID: 29103133
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, Welch K, Bryant J.
    Health Technol Assess; 2010 Sep 23; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.